Loading provider…
Loading provider…
Neurological Surgery Physician in Duarte, CA
NPI: 1114026846Primary Employer
City of Hope Medical - San Bernardino Radiation Oncology
cityofhope.org
HQ Phone
Get MD Behnam's Phone Numberphone_androidMobile
Get MD Behnam's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1991 - 2026
WI State Medical License
1996 - 2007

American Board of Neurological Surgery
Neurological Surgery
UCLA David Geffen School of Medicine/UCLA Medical Center
Residency • Neurological Surgery
1990 - 1996
Internship • Transitional Year
1989 - 1990
David Geffen School of Medicine at UCLA
medschool.ucla.edu
Medical School
Until 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 42 | 54 |
| 2 | 61781Computer-assisted procedure inside the brain | 23 | 25 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 22 | 22 |
| 4 | 69990Use of operating microscope | 21 | 22 |
| 5 | 76998Ultrasonic guidance during surgery | 19 | 20 |
Role of microglia in glioma biology.
Authors: Badie, B, Schartner, J
Journal: Microsc Res Tech
Authors: Maryam Gul, Mike Chen, Mike Chen, Rahul Jandial, Ammar Chaudhry
Journal: Neuroimaging Clin N Am
Lead Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery), BIOLOGICAL: Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery)
Lead Sponsor: City of Hope Medical Center
Collaborators: Bristol-Myers Squibb, National Cancer Institute (NCI), Gateway for Cancer Research
Intervention / Treatment: OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, BIOLOGICAL: Ipilimumab, OTHER: Quality-of-Life Assessment, BIOLOGICAL: IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells
Lead Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, PROCEDURE: Leukapheresis, BIOLOGICAL: HER2(EQ)BBζ/CD19t+ T cells